Literature DB >> 15047540

Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.

O Y Misyurina1, E V Chipitsyna, Y P Finashutina, V N Lazarev, T A Akopian, A M Savicheva, V M Govorun.   

Abstract

For six clinical isolates of Chlamydia trachomatis, in vitro susceptibility to erythromycin, azithromycin, and josamycin has been determined. Four isolates were resistant to all the antibiotics and had the mutations A2058C and T2611C (Escherichia coli numbering) in the 23S rRNA gene. All the isolates had mixed populations of bacteria that did and did not carry 23S rRNA gene mutations.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15047540      PMCID： PMC375314          DOI： 10.1128/AAC.48.4.1347-1349.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria.

Authors:  F Schlünzen; R Zarivach; J Harms; A Bashan; A Tocilj; R Albrecht; A Yonath; F Franceschi
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

3.  Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects.

Authors:  Paolo Scarpellini; Paola Carrera; Annalisa Cavallero; Massimo Cernuschi; Gianni Mezzi; Pier Alberto Testoni; Anna Zingale; Adriano Lazzarin
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  The structures of four macrolide antibiotics bound to the large ribosomal subunit.

Authors:  Jeffrey L Hansen; Joseph A Ippolito; Nenad Ban; Poul Nissen; Peter B Moore; Thomas A Steitz
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

5.  Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.

Authors:  Annie Canu; Brigitte Malbruny; Maëlle Coquemont; Todd A Davies; Peter C Appelbaum; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

6.  Spontaneous erythromycin resistance mutation in a 23S rRNA gene, rrlA, of the extreme thermophile Thermus thermophilus IB-21.

Authors:  S T Gregory; J H Cate; A E Dahlberg
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

7.  Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.

Authors:  Brigitte Malbruny; Kensuke Nagai; Maëlle Coquemont; Bülent Bozdogan; Arjana Tambic Andrasevic; Helena Hupkova; Roland Leclercq; Peter C Appelbaum
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

8.  Ribosomal mutations in Streptococcus pneumoniae clinical isolates.

Authors:  Marja Pihlajamäki; Janne Kataja; Helena Seppälä; John Elliot; Maija Leinonen; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

9.  Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.

Authors:  J Somani; V B Bhullar; K A Workowski; C E Farshy; C M Black
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

10.  The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.

Authors:  L H Hansen; P Mauvais; S Douthwaite
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501
View more
  33 in total

1.  Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.

Authors:  Paul F Riska; Andrei Kutlin; Patrick Ajiboye; Arnold Cua; Patricia M Roblin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

Authors:  Jessica C Seidman; Christian L Coles; Ellen K Silbergeld; Joshua Levens; Harran Mkocha; Lashaunda B Johnson; Beatriz Muñoz; Sheila K West
Journal:  Int J Epidemiol       Date:  2014-03-21       Impact factor: 7.196

4.  Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.

Authors:  Ryoichi Hamasuna; Yukio Osada; Jørgen Skov Jensen
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 5.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

6.  Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.

Authors:  Andrei Kutlin; Stephan Kohlhoff; Patricia Roblin; Margaret R Hammerschlag; Paul Riska
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

7.  Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 8.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 9.  Chlamydia trachomatis today: treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesis.

Authors:  D Dean
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245

10.  A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.

Authors:  Dustin L Johnson; Chris B Stone; David C Bulir; Brian K Coombes; James B Mahony
Journal:  BMC Microbiol       Date:  2009-10-14       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.